TW200501943A - Escitalopram hydrobromide and a method for the preparation thereof - Google Patents

Escitalopram hydrobromide and a method for the preparation thereof

Info

Publication number: TW200501943A
Authority: TW; Taiwan
Prior art keywords: preparation; escitalopram hydrobromide; escitalopram; hydrobromide; citalopram
Prior art date: 2002-12-23

Application number

TW092136380A

Other languages

English (en)

Inventor

Robert Dancer

Hans Petersen

Peter Ellegaard

Lawrence Martel

Original Assignee

Lundbeck & Co As H

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-12-23

Filing date

2003-12-22

Publication date

2005-01-16

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32668635&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW200501943(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-12-22 Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H

2005-01-16 Publication of TW200501943A publication Critical patent/TW200501943A/zh

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Psychiatry (AREA)
Epidemiology (AREA)
Addiction (AREA)
Child & Adolescent Psychology (AREA)
Hospice & Palliative Care (AREA)
Diabetes (AREA)
Hematology (AREA)
Pain & Pain Management (AREA)
Anesthesiology (AREA)
Psychology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Nutrition Science (AREA)
Obesity (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

TW092136380A 2002-12-23 2003-12-22 Escitalopram hydrobromide and a method for the preparation thereof TW200501943A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DKPA200202005		2002-12-23

Publications (1)

Publication Number	Publication Date
TW200501943A true TW200501943A (en)	2005-01-16

Family

ID=32668635

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TW092136380A TW200501943A (en)	2002-12-23	2003-12-22	Escitalopram hydrobromide and a method for the preparation thereof

Country Status (32)

Country	Link
US (1)	US20040167209A1 (zh)
EP (1)	EP1578738B1 (zh)
JP (2)	JP4658613B2 (zh)
KR (1)	KR20050086933A (zh)
CN (1)	CN100349885C (zh)
AR (1)	AR042652A1 (zh)
AT (1)	ATE388947T1 (zh)
AU (1)	AU2003287919B2 (zh)
BR (1)	BR0317623A (zh)
CA (1)	CA2511142A1 (zh)
CY (1)	CY1107451T1 (zh)
DE (1)	DE60319739T2 (zh)
DK (1)	DK1578738T3 (zh)
EA (1)	EA013116B1 (zh)
EG (1)	EG24729A (zh)
ES (1)	ES2298595T3 (zh)
IL (1)	IL169125A0 (zh)
IS (1)	IS2654B (zh)
ME (1)	MEP5808A (zh)
MX (1)	MXPA05005772A (zh)
MY (1)	MY135468A (zh)
NO (1)	NO20053595L (zh)
NZ (1)	NZ540281A (zh)
PE (1)	PE20040924A1 (zh)
PL (1)	PL378275A1 (zh)
PT (1)	PT1578738E (zh)
RS (1)	RS51092B (zh)
TW (1)	TW200501943A (zh)
UA (1)	UA80170C2 (zh)
UY (1)	UY28148A1 (zh)
WO (1)	WO2004056791A1 (zh)
ZA (1)	ZA200504109B (zh)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20050137255A1 (en) *	2002-12-23	2005-06-23	H. Lundbeck A/S	Crystalline escitalopram hydrobromide and methods for preparing the same
BR0317623A (pt) *	2002-12-23	2005-11-29	Lundbeck & Co As H	Escitalopram, composição farmacêutica, e, uso de hidrobrometo de escitalopram
CA2558198A1 (en) *	2004-03-05	2005-09-15	H. Lundbeck A/S	Crystalline composition containing escitalopram oxalate
TWI347942B (en)	2005-06-22	2011-09-01	Lundbeck & Co As H	Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
US7834201B2 (en)	2005-06-22	2010-11-16	H. Lundbeck A/S	Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
AU2006304889A1 (en) *	2005-10-14	2007-04-26	H. Lundbeck A/S	Stable pharmaceutical formulations containing escitalopram and bupropion
AU2006308635A1 (en) *	2005-10-14	2007-05-10	H. Lundbeck A/S	Methods of treating central nervous system disorders with a low dose combination of escitalopram and bupropion
TW200812993A (en) *	2006-05-02	2008-03-16	Lundbeck & Co As H	New uses of escitalopram
ES2687756T3 (es) *	2006-07-11	2018-10-29	Mitsubishi Tanabe Pharma Corporation	Sal de un compuesto de morfolina
WO2008059514A2 (en) *	2006-07-31	2008-05-22	Cadila Healthcare Limited	Process for preparing escitalopram
FR3006594A1 (fr) *	2013-06-11	2014-12-12	Sorin Crm Sas	Microsonde implantable de detection/stimulation incorporant un agent anti-inflammatoire
CN108976188B (zh) *	2017-06-05	2022-12-06	上海奥博生物医药股份有限公司	一种艾司西酞普兰双羟萘酸盐新的制备方法
MX2020003730A (es) *	2017-10-09	2020-08-03	Teva Pharma	Nueva sal y formas en estado solido de escitalopram.
WO2022153262A1 (en)	2021-01-18	2022-07-21	Anton Frenkel	Pharmaceutical dosage form

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US34712A (en) *		1862-03-18		James h
GB1526331A (en) *	1976-01-14	1978-09-27	Kefalas As	Phthalanes
GB8419963D0 (en) *	1984-08-06	1984-09-12	Lundbeck & Co As H	Intermediate compound and method
GB8814057D0 (en) *	1988-06-14	1988-07-20	Lundbeck & Co As H	New enantiomers & their isolation
NZ510858A (en) *	1998-10-20	2003-11-28	H	Method for the preparation of citalopram
AR021155A1 (es) *	1999-07-08	2002-06-12	Lundbeck & Co As H	Tratamiento de desordenes neuroticos
DE69920526T2 (de) *	1999-10-25	2006-02-23	H. Lundbeck A/S	Verfahren zur herstellung von citalopram
JP2002020379A (ja) *	2000-05-02	2002-01-23	Sumika Fine Chemicals Co Ltd	シタロプラム臭化水素酸塩の結晶およびその結晶化方法
US6977306B2 (en) *	2000-05-02	2005-12-20	Sumitomo Chemical Company, Limited	Citalopram hydrobromide crystal and method for crystallization thereof
CA2353693C (en) *	2000-08-10	2003-07-22	H. Lundbeck A/S	Pharmaceutical composition containing citalopram
BR0115908B1 (pt) *	2000-12-04	2011-10-04		processo para a produção de ésteres de ácido graxo.
MEP5908A (xx) *	2001-05-01	2010-02-10	Lundbeck & Co As H	Upotreba enantiomerno čistog escitaloprama
AR034612A1 (es)	2001-06-25	2004-03-03	Lundbeck & Co As H	Proceso para la preparacion del citalopram racemico y/o del s- o r-citalopram mediante la separacion de una mezcla de r- y s-citalopram
BR0317623A (pt) *	2002-12-23	2005-11-29	Lundbeck & Co As H	Escitalopram, composição farmacêutica, e, uso de hidrobrometo de escitalopram
US20050174782A1 (en) *	2003-03-25	2005-08-11	Chapman Leonard T.	Flashlight

2003
- 2003-12-18 BR BR0317623-1A patent/BR0317623A/pt not_active IP Right Cessation
- 2003-12-18 DK DK03779759T patent/DK1578738T3/da active
- 2003-12-18 WO PCT/DK2003/000902 patent/WO2004056791A1/en not_active Ceased
- 2003-12-18 NZ NZ540281A patent/NZ540281A/en not_active Application Discontinuation
- 2003-12-18 CA CA002511142A patent/CA2511142A1/en not_active Abandoned
- 2003-12-18 EA EA200501046A patent/EA013116B1/ru not_active IP Right Cessation
- 2003-12-18 MX MXPA05005772A patent/MXPA05005772A/es active IP Right Grant
- 2003-12-18 AU AU2003287919A patent/AU2003287919B2/en not_active Ceased
- 2003-12-18 PT PT03779759T patent/PT1578738E/pt unknown
- 2003-12-18 CN CNB2003801063775A patent/CN100349885C/zh not_active Expired - Fee Related
- 2003-12-18 KR KR1020057011704A patent/KR20050086933A/ko not_active Ceased
- 2003-12-18 ME MEP-58/08A patent/MEP5808A/xx unknown
- 2003-12-18 PL PL378275A patent/PL378275A1/pl not_active Application Discontinuation
- 2003-12-18 ES ES03779759T patent/ES2298595T3/es not_active Expired - Lifetime
- 2003-12-18 DE DE60319739T patent/DE60319739T2/de not_active Expired - Lifetime
- 2003-12-18 RS YUP-2005/0487A patent/RS51092B/sr unknown
- 2003-12-18 UA UAA200506077A patent/UA80170C2/uk unknown
- 2003-12-18 JP JP2004561083A patent/JP4658613B2/ja not_active Expired - Lifetime
- 2003-12-18 AT AT03779759T patent/ATE388947T1/de not_active IP Right Cessation
- 2003-12-18 EP EP03779759A patent/EP1578738B1/en not_active Expired - Lifetime
- 2003-12-22 TW TW092136380A patent/TW200501943A/zh unknown
- 2003-12-22 MY MYPI20034949A patent/MY135468A/en unknown
- 2003-12-22 AR ARP030104777A patent/AR042652A1/es unknown
- 2003-12-23 UY UY28148A patent/UY28148A1/es not_active Application Discontinuation
- 2003-12-23 US US10/746,913 patent/US20040167209A1/en not_active Abandoned
2004
- 2004-01-05 PE PE2004000013A patent/PE20040924A1/es not_active Application Discontinuation
2005
- 2005-05-17 IS IS7848A patent/IS2654B/is unknown
- 2005-05-20 ZA ZA200504109A patent/ZA200504109B/en unknown
- 2005-06-09 IL IL169125A patent/IL169125A0/en unknown
- 2005-06-22 EG EGNA2005000345 patent/EG24729A/xx active
- 2005-07-25 NO NO20053595A patent/NO20053595L/no not_active Application Discontinuation
2008
- 2008-05-02 CY CY20081100470T patent/CY1107451T1/el unknown
2010
- 2010-10-20 JP JP2010235287A patent/JP2011037893A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
CN1726202A (zh)	2006-01-25
RS20050487A (sr)	2007-06-04
HK1087708A1 (zh)	2006-10-20
NO20053595L (no)	2005-09-05
EA013116B1 (ru)	2010-02-26
EP1578738A1 (en)	2005-09-28
DE60319739T2 (de)	2008-07-17
WO2004056791A1 (en)	2004-07-08
RS51092B (sr)	2010-10-31
DE60319739D1 (de)	2008-04-24
PT1578738E (pt)	2008-04-11
IS7848A (is)	2005-05-17
KR20050086933A (ko)	2005-08-30
BR0317623A (pt)	2005-11-29
PE20040924A1 (es)	2004-12-11
CA2511142A1 (en)	2004-07-08
MXPA05005772A (es)	2005-08-16
AU2003287919B2 (en)	2009-11-12
JP4658613B2 (ja)	2011-03-23
UA80170C2 (en)	2007-08-27
ES2298595T3 (es)	2008-05-16
UY28148A1 (es)	2004-09-30
IS2654B (is)	2010-08-15
JP2006514952A (ja)	2006-05-18
DK1578738T3 (da)	2008-06-30
IL169125A0 (en)	2009-02-11
CN100349885C (zh)	2007-11-21
CY1107451T1 (el)	2012-12-19
US20040167209A1 (en)	2004-08-26
NZ540281A (en)	2008-07-31
MEP5808A (xx)	2010-02-10
MY135468A (en)	2008-04-30
PL378275A1 (pl)	2006-03-20
JP2011037893A (ja)	2011-02-24
ATE388947T1 (de)	2008-03-15
EA200501046A1 (ru)	2005-12-29
AU2003287919A1 (en)	2004-07-14
AR042652A1 (es)	2005-06-29
ZA200504109B (en)	2006-08-30
EG24729A (en)	2010-06-21
EP1578738B1 (en)	2008-03-12

Publication	Publication Date	Title
CY1107451T1 (el)	2012-12-19	Υδροβρωμικον escitalopram και μεθοδος δια την παρασκευη αυτου
MXPA03005222A (es)	2004-03-26	Derivado de metanosulfonamido-benzofurano, su procedimiento de preparacion y su utilizacion como intermediario de sisntesis.
NO331093B1 (no)	2011-10-03	Somatostatinanaloger, fremgangsmåte for fremstilling, farmasøytisk sammensetning og anvendelse derav.
MXPA02009275A (es)	2004-09-06	Metodo para preparar dispersiones de alta presion/alto esfuerzo cortante que contienen ingredientes fisiologicamente activos.
AP1703A (en)	2007-02-26	Heparin-derived polysaccharide mixtures, preparation method and pharmaceutical compositions containing same.
MXPA04001785A (es)	2004-07-08	Benzofurano y derivados de dihidrobenzofurano utiles como agonistas de beta-3 adrenoreceptores.
ZA200309471B (en)	2004-12-06	Method for the preparation of escitalopram.
EA200400455A1 (ru)	2004-10-28	Способ приготовления быстрорастворимой дозировочной формы
ZA200403432B (en)	2005-05-06	Method for the preparation of escitalopram.
AU2002305344A1 (en)	2002-11-18	Ortho-alkylphenol derived mannich detergent composition and concentrate, fuel and method thereof
AU2003236118A1 (en)	2003-10-20	An antispastic, analgetic pharmaceutical composition and the preparation method thereof as well as the quality control technique therefor
IL154776A0 (en)	2003-10-31	Method for the preparation of 21-hydroxy-6, 19-oxidoprogesterone and derivatives thereof
IL150367A0 (en)	2002-12-01	Method for the preparation of citalopram
AU2003201163A1 (en)	2003-07-30	Method for the preparation of lariciresinol, cyclolariciresinol and secoisolariciresinol
NL1017717A1 (nl)	2001-10-01	Gecombineerde plantencoagulaatsamenstelling, werkwijze voor de bereiding ervan en toepassing ervan.
AU2003246840A8 (en)	2003-11-03	Anti-hiv composition, production method thereof and medicament
AU2002245649A1 (en)	2002-09-19	Methods, compositions and kits for preserving antigenicity
EP1515960A4 (en)	2006-07-26	2-THIOXOTHIAZOL DERIVATIVE, METHOD FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF
WO2002004017A3 (en)	2002-12-12	Method for preparing oral vaccines
EP1515952A4 (en)	2007-06-06	PYRAZOL-3-ONE DERIVATIVE METHOD, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF
AU2003271956A1 (en)	2004-05-04	Benzofuran derivatives, formulations and uses thereof
AU2003283508A1 (en)	2004-05-04	.pharmaceutical composition comprising htless thansbgreater than4less than/sbgreater thandless thanspgreater than100less than/spgreater thana receptors, and therapeutic uses thereof
MXPA03008636A (es)	2003-12-08	Derivados de isoquinuclidina, metodo para fabricar los mismos y agentes terapeuticos que contienen estos compuestos.
EP1338275A4 (en)	2005-11-09	Pharmaceutical composition, its use and method of making the same
HRP20070517A2 (en)	2009-05-31	Escitalopram hydrobromide and a method for the preparation thereof